Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1132393

	registered interest
	date	17/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Genito-urinary Medicine: Finance
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans he has to allocate additional funding for the provision of sexual health services in the next four years.
	tabling member constituency	Bermondsey and Old Southwark
	tabling member printed	Neil Coyle
	uin	265528
	answer	answer is ministerial correction date of answer 25/06/2019 answer text <p>The Government provides funding to local authorities for their public health responsibilities, including sexual health services, through a public health grant. It is for individual local authorities to decide their spending priorities based on an assessment of local need, including the need for sexual health services taking account of their statutory duties. They are required by regulations to provide services for sexually transmitted infection testing and treatment and contraception.</p><p>Future funding for local authorities’ public health responsibilities will be determined in the next spending review.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 25/06/2019 16:46:30 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4368 label Biography information for Neil Coyle

1132403

	registered interest
	date	17/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Lumacaftor/ivacaftor
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what contingency plans his Department has put in place in the event that Vertex declines NHS England’s latest offer for the supply of Orkambi.
	tabling member constituency	Birmingham, Selly Oak
	tabling member printed	Steve McCabe
	uin	265417
	answer	answer is ministerial correction date of answer 20/06/2019 answer text <p>NHS England is leading the negotiations with Vertex and has made a revised and improved offer to Vertex that would provide immediate funding for Orkambi, and Symkevi in advance of assessment by the National Institute for Health and Care Excellence (NICE), and expanded access to Kalydeco which is already funded on the National Health Service for certain patients.</p><p>The Government fully supports NICE and NHS England in seeking to ensure access for patients to effective and innovative medicines at a price that represents value to the NHS, and it is not for Ministers to intervene in this process. The Department’s approach remains to urge Vertex to accept NHS England’s generous offer, but we will explore other options to ensure patients can access treatments as soon as possible.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 265418 question first answered 20/06/2019 09:33:36 answering member 4455 label Biography information for Seema Kennedy
	tabling member	298 label Biography information for Steve McCabe

1132404

	registered interest
	date	17/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Lumacaftor/ivacaftor: Clinical Trials
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of launching a large scale clinical trial of the generic version of Orkambi.
	tabling member constituency	Birmingham, Selly Oak
	tabling member printed	Steve McCabe
	uin	265418
	answer	answer is ministerial correction date of answer 20/06/2019 answer text <p>NHS England is leading the negotiations with Vertex and has made a revised and improved offer to Vertex that would provide immediate funding for Orkambi, and Symkevi in advance of assessment by the National Institute for Health and Care Excellence (NICE), and expanded access to Kalydeco which is already funded on the National Health Service for certain patients.</p><p>The Government fully supports NICE and NHS England in seeking to ensure access for patients to effective and innovative medicines at a price that represents value to the NHS, and it is not for Ministers to intervene in this process. The Department’s approach remains to urge Vertex to accept NHS England’s generous offer, but we will explore other options to ensure patients can access treatments as soon as possible.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 265417 question first answered 20/06/2019 09:33:36 answering member 4455 label Biography information for Seema Kennedy
	tabling member	298 label Biography information for Steve McCabe

1132418

	registered interest
	date	17/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Food: Hygiene
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of making it mandatory for restaurants to display their food hygiene ratings in England and Wales.
	tabling member constituency	Ealing Central and Acton
	tabling member printed	Dr Rupa Huq
	uin	265573
	answer	answer is ministerial correction date of answer 26/06/2019 answer text <p>The Food Hygiene Rating Scheme is operated by the Food Standards Agency (FSA) in partnership with local authorities across England, Wales and Northern Ireland.</p><p> </p><p>Food businesses covered by the scheme are provided with stickers showing their rating. Those in Wales and Northern Ireland are already required by law to display the stickers at their premises, while those in England are encouraged to do so.</p><p> </p><p>The FSA considers that mandatory display should extend to England and is currently finalising an evidence-based case for a statutory scheme. The case for extending mandatory display to England is being finalised by the FSA for ministerial consideration and ultimately cross Government approval.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 26/06/2019 16:13:21 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4511 label Biography information for Dr Rupa Huq

1132420

	registered interest
	date	17/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Digital Technology
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure the NHS has access to faster digital technology systems to enable practices to be run more efficiently.
	tabling member constituency	Newcastle-under-Lyme
	tabling member printed	Paul Farrelly
	uin	265459
	answer	answer is ministerial correction date of answer 25/06/2019 answer text <p>We are committed to ensuring that all practices have access to faster digital technology systems to enable to high quality, effective healthcare services that are responsive to all patients’ needs.</p><p>We have rolled out National Health Service WiFi across 96.8% of general practitioner (GP) practices, benefiting the care of an estimated 57.8 million patients. The new Health and Social Care Network (HSCN) arrangements are enabling clinical commissioning groups (CCGs) to obtain faster data network connections for GPs and all GP practices are expected to have migrated from their legacy connectivity to new HSCN services by the end of 2020.</p><p>The fourth edition of the GP IT Operating Model requires CCGs to adopt appropriately-sized HSCN connectivity capable of supporting their current and future GP business needs and states they should upgrade any existing copper-based asymmetric digital subscriber line (ADSL) connections providing primary connectivity to practice premises to fibre-based connections such as Fibre to the Cabinet (FTTC) or Fibre to the Premise (FTTP) as a minimum.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 25/06/2019 16:00:29 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	1436 label Biography information for Paul Farrelly

1132421

	registered interest
	date	17/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Body Modification: Training
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that businesses offering tattooing or piercings possess the appropriate training and qualifications.
	tabling member constituency	Newcastle-under-Lyme
	tabling member printed	Paul Farrelly
	uin	265460
	answer	answer is ministerial correction date of answer 25/06/2019 answer text <p>Local authorities are responsible for regulating and monitoring businesses offering cosmetic body piercing, including ear piercing, permanent tattooing, semi-permanent skin colouring (micropigmentation, semi-permanent make-up and temporary tattooing), electrolysis and acupuncture. Although there is no formal qualification needed for someone to practise in any of these vocations, all LAs require those providing tattooing or piercing to be licensed. Whilst the licensing process will not be dependent upon qualifications held by the operator, they would be required to be competent in methods of cleansing and sterilising of equipment.</p><p>We consider this is an area where progress can be most quickly and effectively made by practitioners, their organisations, industry bodies, training bodies and enforcement authorities working together to agree on suitable standards of good practice and competency.</p><p>Under the Health and Safety at Work Act 1974 and the Management of Health and Safety at Work Regulations 1999, piercing and tattoo businesses have a legal duty to protect the health of employees and persons other than their employees, who may be affected by the practices. This information is available at the following link:</p><p><a href="http://www.hse.gov.uk/legislation/hswa.htm" target="_blank">http://www.hse.gov.uk/legislation/hswa.htm</a></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 25/06/2019 16:09:45 answering member 4455 label Biography information for Seema Kennedy
	tabling member	1436 label Biography information for Paul Farrelly

1132424

	registered interest
	date	17/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Skin Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to reduce the number of cases of melanoma.
	tabling member constituency	East Londonderry
	tabling member printed	Mr Gregory Campbell
	uin	265456
	answer	answer is ministerial correction date of answer 20/06/2019 answer text <p>On 16 June 2014, a local pilot campaign launched in Devon, Cornwall and Somerset to raise awareness of the signs of skin cancer. It encouraged people to tell their doctor if they noticed any unusual or persistent changes to their skin. It ran until 27 July 2014 and included adverts in the press and on local radio, as well as some direct mail to the target group.</p><p> </p><p>Skin Cancer awareness month is an annual awareness campaign that takes place every May. The campaign aims to raise awareness of the dangers of unprotected sun exposure and educate the public about the ways to help prevent skin cancer.</p><p>The Sunbeds (Regulation) Act 2010 came into force in April 2011 in England and Wales to prohibit under-18s from using sunbeds.</p><p> </p><p>Public Health England (PHE) contributed to the revision of the World Health Organization publication “Artificial tanning devices - Public health interventions to manage sunbeds”, which was published in 2017. PHE advises that sunbeds emit ultraviolet radiation, which can cause tanning and sunburn.</p><p> </p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 20/06/2019 14:14:40 answering member 4455 label Biography information for Seema Kennedy
	tabling member	1409 label Biography information for Mr Gregory Campbell

1132427

	registered interest
	date	17/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Genomics: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many patients have received whole genome sequencing through the NHS; and how many of those patients had a type of blood cancer.
	tabling member constituency	Totnes
	tabling member printed	Dr Sarah Wollaston
	uin	265508
	answer	answer is ministerial correction date of answer 20/06/2019 answer text <p>As part of the NHS Long Term Plan, the National Health Service has committed to sequencing 500,000 whole genomes by 2023/24.</p><p>During 2019, the NHS will begin to offer whole genome sequencing (WGS) as part of clinical care for:</p><p>- Seriously ill children likely to have a rare genetic disorder;</p><p>- People with one of 21 rare conditions where current evidence supports early adoption of WGS as a diagnostic test; and</p><p>- People with specific types of cancer for which there is likely to be the greatest patient benefit from using WGS – children with cancer, sarcoma and Acute Myeloid Leukaemia.</p><p> </p><p>As the price of whole genome sequencing falls and the evidence improves, we envisage that it will be extended to more conditions and therefore more patients.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 265509 265510 question first answered 20/06/2019 15:34:08 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4073 label Biography information for Dr Sarah Wollaston

1132428

	registered interest
	date	17/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Genomics: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many patients he estimates will benefit from whole genome sequencing in (a) 2019 and (b) each of the next five years.
	tabling member constituency	Totnes
	tabling member printed	Dr Sarah Wollaston
	uin	265509
	answer	answer is ministerial correction date of answer 20/06/2019 answer text <p>As part of the NHS Long Term Plan, the National Health Service has committed to sequencing 500,000 whole genomes by 2023/24.</p><p>During 2019, the NHS will begin to offer whole genome sequencing (WGS) as part of clinical care for:</p><p>- Seriously ill children likely to have a rare genetic disorder;</p><p>- People with one of 21 rare conditions where current evidence supports early adoption of WGS as a diagnostic test; and</p><p>- People with specific types of cancer for which there is likely to be the greatest patient benefit from using WGS – children with cancer, sarcoma and Acute Myeloid Leukaemia.</p><p> </p><p>As the price of whole genome sequencing falls and the evidence improves, we envisage that it will be extended to more conditions and therefore more patients.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 265508 265510 question first answered 20/06/2019 15:34:08 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4073 label Biography information for Dr Sarah Wollaston

1132429

	registered interest
	date	17/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Genomics
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, when the NHS Genomic Medicine Service will begin performing whole genome sequencing.
	tabling member constituency	Totnes
	tabling member printed	Dr Sarah Wollaston
	uin	265510
	answer	answer is ministerial correction date of answer 20/06/2019 answer text <p>As part of the NHS Long Term Plan, the National Health Service has committed to sequencing 500,000 whole genomes by 2023/24.</p><p>During 2019, the NHS will begin to offer whole genome sequencing (WGS) as part of clinical care for:</p><p>- Seriously ill children likely to have a rare genetic disorder;</p><p>- People with one of 21 rare conditions where current evidence supports early adoption of WGS as a diagnostic test; and</p><p>- People with specific types of cancer for which there is likely to be the greatest patient benefit from using WGS – children with cancer, sarcoma and Acute Myeloid Leukaemia.</p><p> </p><p>As the price of whole genome sequencing falls and the evidence improves, we envisage that it will be extended to more conditions and therefore more patients.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 265508 265509 question first answered 20/06/2019 15:34:08 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4073 label Biography information for Dr Sarah Wollaston